Abstract: Significant advances during the past decade in silicone hydrogel lenses have made them the primary mode for new contact lens wear. Their dominance in the market place is driven largely by the elimination of structural and physiological changes induced by contact lens-induced hypoxia, as exemplified especially by the reduction in limbal redness. However, end-of-day dryness and discomfort still drives many to discontinue lens wear. Evidence also indicates that the rate of serious adverse events, such as microbial keratitis, have not been impacted with the use of silicone hydrogel lenses. Moreover, there are additional challenges relating to 'corneal staining' and corneal infiltrates associated with the incompatibility of lens care product with contact lens polymers. On the other hand, technological advances enabled by the high oxygen platform present opportunities for expanding the use of contact lenses in areas that have exhibited limited uptake in the past such as astigmatism, presbyopia, and importantly myopia control. The challenges and opportunities facing the field will be discussed. C ombining the advantages of a hydrogel with the improved oxygen transmissibility of silicone catapulted silicone hydrogel lenses to glory.
C
ombining the advantages of a hydrogel with the improved oxygen transmissibility of silicone catapulted silicone hydrogel lenses to glory. 1 Silicone hydrogels relegated hypoxic related complications, such as epithelial microcysts, limbal redness, corneal edema, and neovascularization to history. [1] [2] [3] [4] [5] Since their introduction to the market place in 1999, silicone hydrogels have been steadily replacing other materials as the lens material of choice. As evidenced by market trends, a significant percent of first time wearers and refits from other materials are fitted with silicone hydrogels. 6 Initially, silicone hydrogels were fitted to be used on a continuous wear basis, but it was soon evident that complications associated with overnight wear, such as microbial keratitis, some infiltrative events, such as contact lens acute red eye, and corneal infiltrates continued to occur at the same rate as those seen with use extended wear of conventional hydrogels. [7] [8] [9] [10] Clearly, the improved oxygen transmissibility did not reduce this risk. In addition, the increased stiffness associated with the first-generation materials also saw a larger number of mechanical complications such as contact lens papillary conjunctivitis, superior epithelial arcuate lesion, and corneal erosions. 9, 11, 12 Before long, the market responded by moving away from continuous wear to daily wear (DW). 13 At the same time, the introduction of second-and third-generation silicone hydrogels saw advances in the reduced modulus of elasticity, improvements in surface wettability, and silicone hydrogel lenses with a higher water content. 14, 15 The industry also expanded the range of lenses to include astigmatic and presbyopic prescriptions.
CURRENT STATE
Although the improvements in lens materials and surfaces, and change in practice are promising, the trend toward increasing use of silicone hydrogels on a DW basis has not been without issues and has seen the emergence of newer problems related to lens and lens care solution (multipurpose solution [MPS]) incompatibilities. The incompatibility commonly presents as solution induced corneal staining (SICS), and there have been suggestions that it could also result in corneal infiltrates. [16] [17] [18] However, more importantly, in a significant percent of the population, these new contact lens materials are still associated with discomfort and dryness especially toward the end of the day, [19] [20] [21] and this situation continues as a leading factor for lens-related drop outs. Also, although the incidences of many complications have been reduced with the use of DW, they have not been eliminated. 22 Clearly, lens care solution incompatibility and the resulting complications can be reduced to a large extent with the use of silicone hydrogels on a daily disposable (DD) lens wear modality thus eliminating the need for lens care solutions to a large degree. In addition, the sizeable body of data for DD lens wear with conventional hydrogels demonstrate fewer overall complications and greater patient satisfaction with this modality of lens wear compared with other lens modalities. [23] [24] [25] [26] These factors have seen a recent and emerging trend toward the use of silicone hydrogels to be used on a DD wear basis. In 2012, many of the major contact lens-manufacturing companies have already introduced, or are in the process of introducing, a DD silicone hydrogel to the market place.
Will DD silicone hydrogels also be able to reduce or eliminate the remaining issues of adverse events such as microbial keratitis, and discomfort and dryness associated with contact lens wear?
In 1 clinical trial, 27 120 participants were randomized into 1 of 3 lens types: a single conventional hydrogel, etafilcon A (Johnson and Johnson Vision Care, Fort Lauderdale, FL) and 2 silicone hydrogel lenses-narafilcon A and senofilcon A (Johnson and Johnson Vision Care). All lenses were worn bilaterally on a DD regimen. The participants were observed at baseline, 2 weeks, and 1 and 3 months, and subjective ratings were collected on a 1 to 100 rating scale and also in the form of symptom severity (0=none to 4=severe). Interestingly, of the lens types, eyes wearing narafilcon A showed more moderate to severe dryness ( Fig. 1 ) and symptoms of blurred vision at lens wearing visits (P,0.05). A bilateral event of contact lens papillary conjunctivitis, one event of superior epithelial arcuate lesion and one corneal inflammatory adverse event (infiltrative keratitis) were associated with narafilcon A. Additionally, of seven discontinuations (two of which were caused by adverse events described previously), six were from the narafilcon A group. Thus, variation in symptoms and ocular responses might be related to differences in the lens material surface characteristics, design, and fit. Further, in a recent study in which the use of three silicone hydrogel DD contact lenses were evaluated in a group of symptomatic contact lens wearers, mean comfort ratings declined across the day for all silicone hydrogel DDs. 28 These data suggest that problems related to dryness and discomfort might not be fully resolved with the use of silicone hydrogels on a DD wear modality. Data from clinical studies (1-3 months in duration) conducted at Brien Holden Vision Institute (BHVI), Sydney, Australia, and L.V. Prasad Eye Institute, Hyderabad, India (collected since 1987) were analyzed for product that is, lens-related discontinuations across different modalities of lens wear. A total of 2,885 participants, both neophyte and experienced lens wearers wore conventional (n=554) and silicone hydrogels (n=2,331) in these studies. Of the 305 lens-related discontinuations, dryness and discomfort accounted for the highest number of lens-related discontinuations with both conventional and silicone hydrogels worn on a DW and DD basis (Fig. 2) .
In relation to adverse events, data from seven prospective, openlabel clinical trials conducted at BHVI, between 2007 and 2010, were examined to elicit the influence of lens wear modality and lens care solution on adverse events. 29 Two hundred and eighty-three participants wore senofilcon A contact lenses (Johnson and Johnson Vision Care, FL) for 3 months. Of these, 160 participants wore the lenses on a DW basis with use of one of four commercially available MPS, 83 participants used an H 2 O 2 based system, and the remaining 40 participants wore the lenses on a DD basis. In SICS, there was no difference between DD and DW-H 2 O 2 (P.0.05) however SICS was observed in 23.8% in eyes with DW-MPS, and this difference was significant when compared with DD wear (P=0.001). The incidence of corneal infiltrative events in the DD modality was 0%, significantly lower than the DW-MPS group (n=17, 10.6%, P=0.027), but not different from the DW-H 2 O 2 (n=5, 6%, P.0.05). These short term results suggest that silicone hydrogels, when used under DD modality, decrease significantly the incidence of adverse events associated with DW. Clearly long-term results with larger populations are needed to accurately assess the risk of adverse events with DD silicone hydrogels.
Learning from the use of conventional hydrogels on a DD wear basis suggests that although the incidence of complications is less with this wearing modality, it is not eliminated. In a 12-month, prospective, hospital-based epidemiologic study in which all contact lens wearers presenting with a corneal infiltrate/ulcer to a hospital centre were studied, the annual incidence per 10,000 wearers for nonsevere keratitis and severe keratitis was 9.1 and 4.9 for DD lens wear compared with 14.1 and 6.4 for DW of conventional hydrogels. 30 In yet another 12-month, population based surveillance study examining the risk of contact lens related microbial keratitis, the annualized incidence per 10,000 wearers was 1.2 for DW rigid gas permeable CL wearers, 1.9 for DW soft CL wearers, 2.2 for soft CL wearers with occasional overnight use, 2.0 for DD CL wearers and 4.2 for DD CL wearers with occasional overnight use, 11.9 for DW silicone hydrogel CL wearers, 5.5 for occasional overnight use of silicone hydrogels, 19.5 for overnight wear of soft contact lenses and 25.4 for overnight wear of silicone hydrogels. 7 
WHAT IS NEEDED IN THE FUTURE?
Based on the evidence, it seems that adverse events and discomfort and dryness might continue to occur with the use of current DD silicone hydrogel lenses. So what does the future hold? Clearly what is needed is an advance in our understanding of ocular comfort and design and development of contact lenses that offer excellent ocular comfort without the risk of ocular infections.
The BHVI matrix studies comprise a prospective, ongoing series of clinical trials of approximately 1,800 subjects enabling evaluation of various lens materials used on a DW basis in combination with various MPS and a DD modality. The best and least performing lens and lens care product combination on ocular comfort were chosen based on studies involving 1,610 subjects. 31 Further to this, a group of 13 asymptomatic lens wearers and 25 symptomatic lens wearers were randomized to either the best (combination 1: galyfilcon A contact lens, Johnson and Johnson Vision Care, FL, with Aquify multipurpose disinfecting solution, Alcon Laboratories, Fort Worth, TX) or the least performing (combination 2: balafilcon A contact lens, Bausch & Lomb Inc., Rochester, NY with Opti-free Replenish multipurpose disinfecting solution, Alcon Laboratories, Fort Worth, TX) combination of lens and lens care solution for 1-week wear and at the end of the week were crossed over to the remaining combination. Comfort was rated on a scale of 1 to 10 at various points during lens wear. As seen from Figure 3 , in the symptomatic wearers, comfort ratings were significantly higher with the best lens and lens care solution combination (combination 1) at all times during the study in comparison with the least performing combination (combination 2) (P,0.05). A similar but nonsignificant trend was also observed for asymptomatic lens wearers at most of the time points. These results suggest that it is possible to improve relative comfort with the appropriate lens and lens care Of the adverse events, the microbial related events are of significance. Practitioners have adopted to educating wearers on lens care practices to deter risk of developing microbial events through lens contamination. But compliance among general population varies and poor compliance has been identified as a risk factor for development of adverse events. 32 One approach that might be effective in deterring the growth of microorganisms on lens and lens case surfaces is antibacterial surfaces. Currently, antibacterial lens cases that show varying levels of microbicidal efficacy in vitro are available and offer an additional level of protection against lens case contamination. 30 A substantial research effort has been directed to the implementation of antimicrobial technologies for use with contact lenses such as metal compounds including silver and selenium, antiinfectives such as lactoferrin, quorum-sensing compounds such as furanones, and cationic compounds. Although these approaches have shown efficacy in vitro, they are yet to be verified in vivo. [33] [34] [35] [36] [37] Considerable developmental work and evaluation of lenses in a clinical situation is required before such lenses are made available to the public. However, the efforts in this area seem to be promising as a recent study reporting on the use of antibacterial silver infused galyfilcon A contact lenses in a 6-month masked study reported no differences in vision and ocular health. 38 Finally, accumulating evidence in the recent years suggests that contact lenses have a significant role to play in managing refractive errors in children and also in controlling the progression of myopia. [39] [40] [41] Myopia manifests in early childhood and most often continues to progress for a considerable number of years. In addition to the health burden associated with increasing levels of myopia and the risk of sight-threatening eye conditions, the societal burden is significant, 42 and therefore, strategies in controlling the rate of progression of myopia have significant benefits. Traditional optical strategies for myopia have focused mostly on the optical state at the fovea and have shown little benefit in their ability to control the rate of progression of myopia. In this regard, there have been recent and exciting developments with attempts to influence the peripheral refractive error state or simultaneously induce a myopic defocus state over the retina to control myopia progression. Preliminary results with these approaches using contact lenses have been encouraging. Contact lenses specially designed to reduce peripheral hyperopic defocus have been shown to control the rate of progression of myopia by up to 40%. 41, 43 Also contact lenses aiming to simultaneously provide myopic defocus to retina have shown to reduce the rate of progression by 30% or more in most children in comparison to single vision contact lenses. 44 In addition, a study comparing bifocal soft contact lenses with single vision soft contact lenses found a significant slowing in the myopia progression with bifocal contact lenses. 45 This exciting development paves the way for a significant expansion of the contact lens market to include young myopes. However, despite beneficial evidence of contact lens wear in children and the ability of children to independently manage lens care, concerns regarding complications and adverse events with the use of contact lenses in children have limited the uptake of contact lenses in children. Although it seems to be less of a problem in children compared with in adults, there have been reports of children complaining of dryness with contact lens wear. 46, 47 Also, despite the sizeable population, presbyopic fits account for only 10% or less of all contact lens fits. 48 The primary reasons for the low usage of contact lenses in this population are said to be related to vision and comfort.
In summary, since the introduction of the first lens in 1999, silicone hydrogels have captured a significant share of the contact lens market and there have been technological advances in materials and surfaces. The issues that are remaining relate to improving the safety and comfort profile of contact lenses and the need to take into account the requirements of specific populations such as children and presbyopes to further grow the usage of these lenses in the coming years.
